Biotech start-up Vaccitech files for US IPO
Vaccitech owns the technology behind the Covid-19 vaccine developed by Oxford and AstraZeneca
07 April 2021 - 17:20
Bengaluru — Biotech start-up Vaccitech, which owns the technology behind the Covid-19 vaccine developed by Oxford and AstraZeneca, has confidentially filed for an initial public offering (IPO) in the US, the Financial Times reported on Wednesday.
The start-up could price its offering as early as this month, the report said, citing people familiar with the matter...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.